| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.67M | 10.67M | 16.17M | 14.22M | 10.23M | 2.07M |
| Gross Profit | 10.67M | 10.67M | 7.60M | 13.62M | 7.16M | 4.55M |
| EBITDA | 18.63M | 9.93M | 8.99M | 9.62M | 6.26M | 1.30M |
| Net Income | -3.13M | -3.13M | 70.49K | 3.21M | 3.29M | 1.27M |
Balance Sheet | ||||||
| Total Assets | 150.73M | 150.73M | 112.84M | 77.82M | 53.08M | 24.16M |
| Cash, Cash Equivalents and Short-Term Investments | 8.64M | 8.64M | 46.83M | 46.16M | 13.60M | 4.49M |
| Total Debt | 130.76M | 130.76M | 92.67M | 58.14M | 41.53M | 17.26M |
| Total Liabilities | 134.96M | 134.96M | 96.64M | 61.10M | 44.24M | 19.00M |
| Stockholders Equity | 15.76M | 15.76M | 16.20M | 16.72M | 8.84M | 5.16M |
Cash Flow | ||||||
| Free Cash Flow | -1.82M | -1.82M | 2.28M | 1.35M | 4.62M | 301.77K |
| Operating Cash Flow | -1.81M | -1.81M | 2.71M | 1.38M | 4.62M | 350.20K |
| Investing Cash Flow | -15.14K | -15.14K | -435.22K | -946.40K | -3.49M | 953.95K |
| Financing Cash Flow | 3.63M | 3.63M | -1.19M | 2.59M | 129.15K | -213.32K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | AU$112.38M | 6.93 | 9.31% | ― | -5.73% | -36.36% | |
55 Neutral | AU$444.90M | 22.32 | 12.36% | 2.86% | -26.30% | 40.12% | |
53 Neutral | €78.52M | -120.16 | -0.15% | ― | 5.03% | 52.31% | |
50 Neutral | AU$382.74M | 28.27 | 12.27% | 2.81% | 24.56% | 59.32% | |
46 Neutral | AU$11.84M | -2.27 | -34.88% | ― | 43.00% | -6078.57% | |
41 Neutral | AU$3.17M | -0.66 | -444.41% | ― | -37.25% | 27.45% |
Finexia Financial Group Limited has announced a change in its registered office and principal place of business, effective immediately. This strategic move is part of the company’s ongoing efforts to enhance its operational efficiency and better position itself within the financial services industry.
Finexia Financial Group Limited announced the results of its 2025 Annual General Meeting, where all resolutions were passed by poll. The meeting included the adoption of the Remuneration Report and the re-election of Daniel Ritchie as Director, indicating strong support from shareholders for the company’s current management and strategic direction.
Finexia Financial Group Limited faced a challenging 2025 financial year, marked by a record revenue of $23.8 million but overshadowed by significant operational setbacks. The company dealt with a major borrower’s default, leading to the establishment of a recovery platform for its Childcare Income Fund, and implemented a series of governance and financial oversight improvements. Despite reporting a net loss of $6.20 million, Finexia’s core private credit strategy showed positive growth, with loan assets nearly doubling. Leadership changes, including the return of Neil Sheather as CEO, aim to stabilize operations and restore stakeholder confidence.
Finexia Financial Group Limited announced a change in the director’s interest, specifically concerning Robert Spano. The change involved the expiration of 1,666,667 unlisted options held indirectly through RLS Network Holdings Pty Ltd ATF Spano IMA Trust, with no consideration involved. This adjustment reflects a reduction in the director’s indirect holdings, potentially impacting the company’s governance dynamics and signaling a shift in the director’s investment strategy.
Finexia Financial Group Limited announced a change in the director’s interest, as Daniel Blackwood Ritchie disposed of 1,666,667 unlisted options that were exercisable at $0.30 per share, which expired on November 19, 2025. This change leaves Ritchie with no direct interest in these securities, though he retains an indirect interest through Factory Capital GP Ltd. The announcement reflects a routine update in the company’s governance and does not involve any financial consideration, suggesting a neutral impact on the company’s operations and market positioning.
Finexia Financial Group Ltd announced the cessation of 5,000,001 securities due to the expiry of options without exercise or conversion as of November 19, 2025. This cessation reflects a routine adjustment in the company’s capital structure, which may impact stakeholders by altering the available securities and potentially influencing market perceptions of the company’s financial strategies.
Finexia Financial Group Ltd has announced a change in the director’s interest, specifically involving Neil Sheather. The change reflects an acquisition of 144,493 fully paid ordinary shares valued at $18,524.95, resulting in a new total of 1,776,735 shares held indirectly. This transaction, conducted on-market, signifies a strategic move in the company’s governance and could impact stakeholders by potentially altering the director’s influence and decision-making capacity within the company.
Finexia Financial Group Limited, listed on the Australian Securities Exchange under the ticker FNX, has announced that the suspension of its trading securities will be lifted. This follows the company’s release of an announcement addressing recent media speculation, allowing for the reinstatement of its securities to quotation.
Finexia Financial Group Limited has addressed recent media speculation regarding a potential reverse listing transaction with Salter Brothers, clarifying that discussions were preliminary and have now ceased. The company confirms it is not engaged in any negotiations for such a transaction and seeks the reinstatement of its securities on the ASX, maintaining its commitment to continuous disclosure obligations.
Finexia Financial Group Limited has announced its Annual General Meeting (AGM) scheduled for November 26, 2025, at Aurora Place in Sydney. The company emphasizes the importance of shareholder participation and provides multiple methods for submitting proxy votes. Shareholders are encouraged to monitor the company’s website and ASX announcements for any updates regarding the meeting.
Finexia Financial Group Ltd has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, confirming that the company has followed these guidelines throughout the reporting period. This disclosure is part of the company’s commitment to transparency and accountability, which is crucial for maintaining stakeholder trust and ensuring robust governance practices.
Finexia Financial Group Ltd has released its annual report for the year ending June 30, 2025. The report includes detailed financial statements and disclosures, reflecting the company’s financial performance and position. This release is crucial for stakeholders to assess Finexia’s operational health and strategic direction in the competitive financial services market.
Finexia Financial Group Limited has announced an additional impairment adjustment of $2.2 million to its investment in The Stay Company Income Fund, bringing the total impairment for FY25 to over $6.2 million. This adjustment increases the company’s reported loss before tax for the fiscal year to $6.8 million, highlighting significant financial challenges. Additionally, the company has written down a receivable related to Dragonfly Biosciences by $543,039 due to recovery doubts, impacting the financial position as reported in the 2025 Annual Report.